From a public health perspective, our results advocate for integrated anaemia screening in obese populations that includes inflammation‐corrected iron markers (e.g., BRINDA‐adjusted ferritin, soluble transferrin receptor) and CRP or hepcidin measurements [16]. The gene discussed is TFRC; the disease is anemia.